đź”— Share this article Chancellor Rachel Reeves Aims for Specific Measures on Bills in Upcoming Financial Plan Treasury head Rachel Reeves has stated she is preparing "focused action to address cost of living pressures" in next month's financial statement. Speaking to media outlets, she emphasized that curbing inflation is a joint task of both the administration and the central bank. The UK's price growth is expected to be the most elevated among the Group of Seven industrialized countries this year and next. Potential Energy Bill Interventions Reports indicate the administration could intervene to reduce energy bills, for example by cutting the current 5% rate of value-added tax charged on energy. Another approach is to reduce some of the government charges currently added to bills. Fiscal Constraints and Analyst Expectations The administration will obtain the latest assessment from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for these actions. The view from the majority of experts is that the Chancellor will have to introduce higher taxes or spending cuts in order to meet her self-imposed debt limits. Earlier on Thursday, analysis showed there was a ÂŁ22 billion gap for the Treasury chief to fill, which is at the more modest range of projections. "It is a joint job between the Bank of England and the government to continue tackling some of the causes of inflation," Reeves stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution. Tax Commitments and International Concerns While a great deal of the focus has been on probable tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not changed her commitment to campaign commitments not to increase tax levels on earnings tax, sales tax or National Insurance. She blamed an "unpredictable world" with increasing geopolitical and commercial concerns for the fiscal tax moves, probably to be targeted on those "wealthiest." International Trade Tensions Commenting on apprehensions about the UK's economic relations with China she said: "The UK's security interests invariably take priority." Recent announcement by Chinese authorities to increase trade restrictions on rare earths and other materials that are essential for advanced tech production led US President the US President to propose an additional 100% tariff on goods from the Asian country, raising the possibility of an all-out commercial conflict between the two economic giants. The American finance chief labeled the Chinese decision "commercial pressure" and "a global supply chain power grab." Asked about accepting the American proposal to participate in its conflict with China, the Chancellor said she was "deeply worried" by China's actions and called on the Chinese government "to avoid restrictions and restrict access." She said the move was "bad for the world economy and generates additional obstacles." "In my view there are sectors where we should challenge Chinese policies, but there are also valuable chances to trade with China's economy, including banking sector and other areas of the economy. We've got to maintain that balance appropriate." The Treasury chief also stated she was collaborating with international partners "on our own essential resources approach, so that we are reduced dependence." NHS Drug Costs and Investment Reeves also recognized that the cost the NHS pays for medicines could increase as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital. Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or canceling investments in the United Kingdom, with some attributing the modest returns they are getting. Recently, the government science advisor said the cost the NHS pays for medicines would need to go up to halt companies and drug research funding leaving the UK. The Chancellor stated to media: "It has been observed because of the payment system, that clinical trials, new drugs have not been available in the United Kingdom in the manner that they are in other EU nations." "We want to ensure that people getting care from the NHS are can access the top life-saving drugs in the world. And so we are looking at all of that, and... aiming to attract increased funding into Britain."